Walleye Capital LLC

Position in CRON — Cronos Group Inc.

CIK 1758720 NEW YORK, NY

Back to CRON Full portfolio

Position in CRON

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$15,745

-$30,969 QoQ

Shares Held

6,273

-64.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRON Over Time

Shares Held

Position Value (USD)

Derivatives in CRON

reported options exposure · as of Mar 31, 2026

CallValue

$57,730

CallShares

23,000

PutValue

$12,299

PutShares

4,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Walleye Capital LLC holds $49,633,459 across 26 Drug Manufacturers - Specialty & Generic names. CRON ranks #25 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ANIP	Ani Pharmaceuticals Inc	183,075	$14,078,467
2	HIMS	Hims & Hers Health, Inc.	325,753	$6,762,632
3	BHC	Bausch Health Companies Inc.	1,177,370	$6,357,798
4	TAK	Takeda Pharmaceutical Co Ltd	260,817	$4,830,330
5	BIOA	BioAge Labs, Inc.	151,674	$2,652,778
6	ZTS	Zoetis Inc.	21,328	$2,521,182
7	AQST	Aquestive Therapeutics, Inc.	584,977	$2,427,654
8	ETON	Eton Pharmaceuticals, Inc.	81,963	$2,022,846

All Filings in CRON

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,299	4,900	-78.7%	Put	Sole	2026-05-13
2026-03-31	$57,730	23,000	+266.7%	Call	Sole	2026-05-13
2026-03-31	$15,745	6,273	-45.5%	Shares	Sole	2026-05-13
2025-12-31	$30,245	11,500	-35.3%	Put	Sole	2026-02-13
2025-12-31	$46,714	17,762	-22.8%	Shares	Sole	2026-02-13
2025-12-31	$60,490	23,000	—	Call	Sole	2026-02-13
No filing history on record for this holder in this stock.